In an exciting breakthrough that may have implications for stem cell-based treatment of heart disease, the lab of Dr. Deok-Ho Kim at the Institute for Stem Cell and Regenerative Medicine […] Read More
Drug response screening of leukemia stem cells offers clues to relapse and suggests ways to improve patient-specific therapies Advances in rapid screening of leukemia cells for drug susceptibility and resistance […] Read More
Two University of Washington Cardiologists received honors at Northwestern University’s 14th Annual Northwestern Cardiovascular Young Investigator Forum. Read More
A multidisciplinary team including ISCRM faculty member Tom Reh has been awarded a grant from the The National Eye Institute (NEI) as part of the NEI Audacious Goals Initiative (AGI) for Regenerative Medicine, a five-year, $30 million program that seeks to catalyze new treatments for blinding conditions like glaucoma, age-related macular degeneration, retinitis pigmentosa, and other degenerative eye diseases. Read More
Collaboration is the engine of scientific progress at UW Medicine and at the Institute of Stem Cell & Regenerative Medicine (ISCRM), where 130 researchers are developing stem cell-based approaches to treat diseases affecting nearly every organ and system in the human body. Read More
An interdisciplinary team led by ISCRM Faculty Member Deok-Ho Kim has been awarded a new NIH-CASIS Tissue Chips in Space UG3/UH3 grant to support research that aims to improve our understanding of how extended periods in microgravity affect the functional capacity of human myocardial tissue and that could have significant impact on the development of deep space missions in the near future. The work funded by the grant will involve two separate missions to the International Space Station. Read More
Acute lymphocytic leukemia (ALL) is the most common type of childhood cancer, representing approximately 25% of cancer diagnoses in children 0-15. More than 3,000 new cases of ALL are diagnosed every year in the United States - and the incidence rate is rising. Read More